Towards establishing a method to screen for inhibitors of essential genes in mycobacteria: evaluation of the acetamidase promoter
- PMID: 16757153
- DOI: 10.1016/j.ijantimicag.2006.01.012
Towards establishing a method to screen for inhibitors of essential genes in mycobacteria: evaluation of the acetamidase promoter
Abstract
As a successful pathogen, Mycobacterium tuberculosis has effectively infected one-third of the world's population. Despite the existence of compound libraries developed by recent advances in combinatorial chemistry, few compounds have been screened against M. tuberculosis. The use of a regulable promoter to control the level of expression of a drug target in living organisms has been shown to be advantageous compared with targetless whole-cell-based or in vitro biochemical screening approaches towards antibiotic discovery. In this study, we demonstrate that the acetamidase promoter from Mycobacterium smegmatis responds in a dose-dependent manner to different concentrations of its inducer acetamide. Using this promoter to regulate expression of a zeocin resistance gene in M. smegmatis, we show that the test strain exhibits increased sensitivity to zeocin at a low concentration of acetamide compared with a fully resistant phenotype at high doses of the inducer. This model system has indicated the feasibility of using a regulable promoter in designing a whole-cell-based high throughput screen for specific inhibitors against potential drug targets of M. tuberculosis.
Similar articles
-
Instability of the acetamide-inducible expression vector pJAM2 in Mycobacterium tuberculosis.Plasmid. 2006 Jan;55(1):81-6. doi: 10.1016/j.plasmid.2005.06.005. Epub 2005 Aug 24. Plasmid. 2006. PMID: 16125237
-
Gene essentiality testing in mycobacterium smegmatis using specialized transduction.Methods Mol Biol. 2009;465:325-36. doi: 10.1007/978-1-59745-207-6_22. Methods Mol Biol. 2009. PMID: 20560066
-
Identification and characterization of the regulatory elements of the inducible acetamidase operon from Mycobacterium smegmatis.Can J Microbiol. 2007 May;53(5):599-606. doi: 10.1139/W06-147. Can J Microbiol. 2007. PMID: 17668018
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.Acc Chem Res. 2008 Jan;41(1):11-20. doi: 10.1021/ar700156e. Acc Chem Res. 2008. PMID: 18193820 Review.
Cited by
-
Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.J Bacteriol. 2010 Jul;192(14):3661-8. doi: 10.1128/JB.00312-10. Epub 2010 May 14. J Bacteriol. 2010. PMID: 20472794 Free PMC article.
-
An IPTG Inducible Conditional Expression System for Mycobacteria.PLoS One. 2015 Aug 6;10(8):e0134562. doi: 10.1371/journal.pone.0134562. eCollection 2015. PLoS One. 2015. PMID: 26247874 Free PMC article.
-
Essentiality Assessment of Cysteinyl and Lysyl-tRNA Synthetases of Mycobacterium smegmatis.PLoS One. 2016 Jan 21;11(1):e0147188. doi: 10.1371/journal.pone.0147188. eCollection 2016. PLoS One. 2016. PMID: 26794499 Free PMC article.
-
Gene expression of Mycobacterium tuberculosis putative transcription factors whiB1-7 in redox environments.PLoS One. 2012;7(7):e37516. doi: 10.1371/journal.pone.0037516. Epub 2012 Jul 19. PLoS One. 2012. PMID: 22829866 Free PMC article.
-
Methionine aminopeptidases from Mycobacterium tuberculosis as novel antimycobacterial targets.Chem Biol. 2010 Jan 29;17(1):86-97. doi: 10.1016/j.chembiol.2009.12.014. Chem Biol. 2010. PMID: 20142044 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials